Browsing by Author "Jevtic, Miroslav (57214026067)"
Now showing 1 - 3 of 3
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Trends in tuberculosis notification and mortality and factors associated with treatment outcomes in Serbia, 2005 to 2015(2020) ;Stosic, Maja (57203866961) ;Grujicic, Sandra Sipetic (56676073300) ;Grgurevic, Anita (12780453700) ;Kuruc, Vesna (23980302700) ;Ristic, Lidija (7003923591) ;Antonijevic, Gordana (6506073767) ;Jevtic, Miroslav (57214026067) ;Plavsa, Dragana (57205675028)Vukicevic, Tatjana Adzic (59158046400)Background: Previously a country with medium tuberculosis (TB) burden, Serbia almost reached a low TB burden during the period 2005 to 2015. Aim: The aim of this study was to analyse the trends in notification rates and treatment success rates as well as to identify predictors of treatment outcomes. Methods: We performed a trend analysis and logistic regression analysis of 17,441 TB cases registered from 2005 to 2015 in all health facilities in Serbia, to identify predictors of treatment success, loss to follow-up and mortality. Results: From 2005 to 2015, TB notification rate and mortality in Serbia decreased but treatment success remained below the global target. Loss to follow-up was associated with retreatment (odds ratio (OR) = 2.38; 95% confidence interval (CI): 2.08-2.77), male sex (OR = 1.57; 95% CI: 1.39-1.79), age younger than 65 years (OR = 1.37; 95% CI: 1.20-1.51), lower education level (OR = 2.57; 95% CI: 1.74-3.80) and pulmonary TB (OR = 1.28; 95% CI: 1.06-1.56). Deaths were more frequent in retreatment cases (OR = 1.39; 95% CI: 1.12-1.61), male patients (OR = 1.34; 95% CI: 1.19-1.52), those 65 years and older (OR = 4.34; 95% CI: 4.00-5.00), those with lower education level (OR = 1.63; 95% CI: 1.14-2.33) and pulmonary TB (OR = 2.24; 95% CI: 1.78-2.83). Conclusions: Special interventions should be implemented to address groups at risk of poor treatment outcome. © 2020 European Centre for Disease Prevention and Control (ECDC). All rights reserved. - Some of the metrics are blocked by yourconsent settings
Publication Trends in tuberculosis notification and mortality and factors associated with treatment outcomes in Serbia, 2005 to 2015(2020) ;Stosic, Maja (57203866961) ;Grujicic, Sandra Sipetic (56676073300) ;Grgurevic, Anita (12780453700) ;Kuruc, Vesna (23980302700) ;Ristic, Lidija (7003923591) ;Antonijevic, Gordana (6506073767) ;Jevtic, Miroslav (57214026067) ;Plavsa, Dragana (57205675028)Vukicevic, Tatjana Adzic (59158046400)Background: Previously a country with medium tuberculosis (TB) burden, Serbia almost reached a low TB burden during the period 2005 to 2015. Aim: The aim of this study was to analyse the trends in notification rates and treatment success rates as well as to identify predictors of treatment outcomes. Methods: We performed a trend analysis and logistic regression analysis of 17,441 TB cases registered from 2005 to 2015 in all health facilities in Serbia, to identify predictors of treatment success, loss to follow-up and mortality. Results: From 2005 to 2015, TB notification rate and mortality in Serbia decreased but treatment success remained below the global target. Loss to follow-up was associated with retreatment (odds ratio (OR) = 2.38; 95% confidence interval (CI): 2.08-2.77), male sex (OR = 1.57; 95% CI: 1.39-1.79), age younger than 65 years (OR = 1.37; 95% CI: 1.20-1.51), lower education level (OR = 2.57; 95% CI: 1.74-3.80) and pulmonary TB (OR = 1.28; 95% CI: 1.06-1.56). Deaths were more frequent in retreatment cases (OR = 1.39; 95% CI: 1.12-1.61), male patients (OR = 1.34; 95% CI: 1.19-1.52), those 65 years and older (OR = 4.34; 95% CI: 4.00-5.00), those with lower education level (OR = 1.63; 95% CI: 1.14-2.33) and pulmonary TB (OR = 2.24; 95% CI: 1.78-2.83). Conclusions: Special interventions should be implemented to address groups at risk of poor treatment outcome. © 2020 European Centre for Disease Prevention and Control (ECDC). All rights reserved. - Some of the metrics are blocked by yourconsent settings
Publication Tuberculosis and COVID-19 co-infection in Serbia: Pandemic challenge in a low-burden country(2022) ;Adzic-Vukicevic, Tatjana (56888756300) ;Stosic, Maja (57203866961) ;Antonijevic, Gordana (6506073767) ;Jevtic, Miroslav (57214026067) ;Radovanovic-Spurnic, Aleksandra (57191847101)Velickovic, Jelena (29567657500)Introduction: COVID-19 and tuberculosis (TB) represent global threats to the public health system. The impact of COVID-19 on TB results in a reduction in the number of notified TB cases, delayed diagnosis and treatment, and increased case fatality and mortality rates. The aim of the study was to analyze the TB/COVID-19 co-infected cohort in Serbia as a low-burden country and compare it to the global TB/COVID-19 cohort. Methods: A retrospective analysis was done on 53 TB and COVID-19 co-infected patients treated in COVID hospital “Batajnica” in Belgrade and Special Hospital for Pulmonary Diseases “Ozren” Sokobanja in the period from 6 March 2020 to 1 April 2022. A comparative analysis with the global cohort published recently was also performed. Results: TB/COVID-19 cohort in Serbia included significantly fewer migrants and diabetes cases, but more cases with chronic respiratory diseases compared to the global. Descriptive analysis of TB cases in the Serbian TB/COVID-19 cohort showed fewer cases diagnosed with sputum smear and Gene Xpert/HAIN, fewer EPTB and mono-resistant cases, and more cases diagnosed with solid culture, unilateral pulmonary infiltrate (with bilateral cavity lesions), and bilateral pulmonary infiltrate (no cavities) compared to TB/COVID-19 cases worldwide. Nasal congestion and fever were more common COVID-19 symptoms in the global cohort. Radiology was more commonly used for the diagnosis of COVID-19 in Serbia. Typical bilateral ground opacities were less common among Serbian patients. Serbian patients spent fewer days in the hospital and achieved a higher PCR conversion rate and TB treatment success rate. Conclusion: The Serbian TB/COVID-19 cohort achieved a higher treatment success rate compared to the global cohort. Encouraging vaccination against SARS-CoV-2 for people with a current or past TB disease, as well as rapid diagnosis and targeted treatment of TB in highly specialized pulmonology institutions, presents key points to avoid excessive morbidity and mortality. Copyright © 2022 Adzic-Vukicevic, Stosic, Antonijevic, Jevtic, Radovanovic-Spurnic and Velickovic.